MB
MPM BioImpact Portfolio holdings
AUM
$577M
This Quarter Return
-11.01%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$645M
AUM Growth
+$645M
(+5.9%)
Cap. Flow
+$142M
Cap. Flow
% of AUM
22.05%
Top 10 Holdings %
Top 10 Hldgs %
72.39%
Holding
33
New
19
Increased
7
Reduced
3
Closed
–
Top Buys
| 1 |
Intellia Therapeutics
NTLA
|
$21.8M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$10.1M |
| 3 |
Cytokinetics
CYTK
|
$8.84M |
| 4 |
Verastem
VSTM
|
$8.7M |
| 5 |
EPZM
Epizyme, Inc
EPZM
|
$8.4M |
Top Sells
| 1 |
ITOS
iTeos Therapeutics
ITOS
|
$6.25M |
| 2 |
Cullinan Oncology
CGEM
|
$6M |
| 3 |
Repare Therapeutics
RPTX
|
$951K |
Sector Composition
| 1 | Healthcare | 94.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
26
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| $4.81M | 0.75% |
+861,858
| New | +$4.81M |
|
|
LHDX
27
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $4.39M | 0.68% |
+578,114
| New | +$4.39M |
|
28
Revolution Medicines
RVMD
$7.43B
| $4.13M | 0.64% |
+150,000
| New | +$4.13M |
|
|
AVDL
29
Avadel Pharmaceuticals
AVDL
$1.42B
| $3.92M | 0.61% |
+400,000
| New | +$3.92M |
|
|
INZY
30
DELISTED
Inozyme Pharma
INZY
| $3.72M | 0.58% |
+320,724
| New | +$3.72M |
|
31
Axsome Therapeutics
AXSM
$6.09B
| $3.63M | 0.56% |
+110,155
| New | +$3.63M |
|
32
Black Diamond Therapeutics
BDTX
$164M
| $2.1M | 0.33% |
+248,506
| New | +$2.1M |
|